Related Experiment Video
Updated: Aug 28, 2025

Preparation of Exosomes for siRNA Delivery to Cancer Cells
Published on: December 5, 2018
Emerging innovations on exosome-based onco-therapeutics
Xiaofeng Dai1,2, Yongju Ye3, Fule He3
1Wuxi School of Medicine, Jiangnan University, Wuxi, China.
Exosomes, nano-sized vesicles, show promise for cancer diagnosis and therapy. Combining them with cold atmospheric plasma may enhance cancer treatment strategies.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Exosomes are nano-sized extracellular vesicles critical for intercellular communication.
- They possess inherent therapeutic properties and stability, making them suitable for clinical applications.
- Exosomes are explored for diagnosing and treating various diseases, particularly cancers.
Purpose of the Study:
- To review the therapeutic potential of exosomes in cancer management.
- To discuss current innovations and challenges in exosome-based cancer therapies.
- To explore the synergistic potential of cold atmospheric plasma with exosomes for cancer treatment.
Main Methods:
- Literature review of exosome-based cancer therapeutics.
- Analysis of exosome functionalities and stability for clinical translation.
- Exploration of cold atmospheric plasma as an adjunct therapy for exosome-based innovations.
Main Results:
- Exosomes offer a versatile platform for cancer diagnosis and therapeutics due to their stability and cargo.
- Current exosome-based strategies show promise but face challenges in clinical translation.
- Cold atmospheric plasma presents a novel approach to enhance exosome-based cancer therapies.
Conclusions:
- Exosomes hold significant potential for advancing cancer treatment strategies.
- Overcoming clinical translation challenges is crucial for realizing the full therapeutic benefits of exosomes.
- The integration of cold atmospheric plasma could unlock new avenues for effective exosome-based onco-therapeutics.
More Related Videos
08:49Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Published on: May 27, 2016
09:30Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes
Published on: May 24, 2019
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy